0
Research Papers

A Finite Element Study on Variations in Mass Transport in Stented Porcine Coronary Arteries Based on Location in the Coronary Arterial Tree

[+] Author and Article Information
Joseph T. Keyes

Graduate Interdisciplinary Program in Biomedical Engineering,
The University of Arizona,
P.O. Box 210240,
Tucson, AZ 85721
e-mail: keyesj@email.arizona.edu

Bruce R. Simon

Department of Aerospace and Mechanical Engineering,
The University of Arizona,
1130 N Mountain Ave.,
Tucson, AZ 85721
e-mail: simonb@email.arizona.edu

Jonathan P. Vande Geest

Graduate Interdisciplinary Program in Biomedical Engineering,
The University of Arizona,
P.O. Box 210240,
Tucson, AZ 85721;
Department of Aerospace and Mechanical Engineering,
The University of Arizona,
1130 N Mountain Ave.,
Tucson, AZ 85721;
Department of Biomedical Engineering,
The University of Arizona,
P.O. Box 210020,
Tucson, AZ 85721;
BIO5 Institute for Biocollaborative Research,
The University of Arizona,
1657 East Helen Street,
Tucson, AZ 85721
e-mail: jpv1@email.arizona.edu

1Corresponding author.

Contributed by the Bioengineering Division of ASME for publication in the JOURNAL OF BIOMECHANICAL ENGINEERING. Manuscript received November 14, 2012; final manuscript received March 25, 2013; accepted manuscript posted April 4, 2013; published online May 9, 2013. Assoc. Editor: Dalin Tang.

J Biomech Eng 135(6), 061008 (May 09, 2013) (11 pages) Paper No: BIO-12-1556; doi: 10.1115/1.4024137 History: Received November 14, 2012; Revised March 25, 2013; Accepted April 04, 2013

Drug-eluting stents have a significant clinical advantage in late-stage restenosis due to the antiproliferative drug release. Understanding how drug transport occurs between coronary arterial locations can better help guide localized drug treatment options. Finite element models with properties from specific porcine coronary artery sections (left anterior descending (LAD), right (RCA); proximal, middle, distal regions) were created for stent deployment and drug delivery simulations. Stress, strain, pore fluid velocity, and drug concentrations were exported at different time points of simulation (0–180 days). Tests indicated that the highest stresses occurred in LAD sections. Higher-than-resting homeostatic levels of stress and strain existed at upwards of 3.0 mm away from the stented region, whereas concentration of species only reached 2.7 mm away from the stented region. Region-specific concentration showed 2.2 times higher concentrations in RCA artery sections at times corresponding to vascular remodeling (peak in the middle segment) compared to all other segments. These results suggest that wall transport can occur differently based on coronary artery location. Awareness of peak growth stimulators and where drug accumulation occurs in the vasculature can better help guide local drug delivery therapies.

FIGURES IN THIS ARTICLE
<>
Copyright © 2013 by ASME
Your Session has timed out. Please sign back in to continue.

References

Hwang, C. W., Wu, D., and Edelman, E. R., 2001, “Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery,” Circulation, 104(5), pp. 600–605. [CrossRef] [PubMed]
Hwang, C. W., Wu, D., and Edelman, E. R., 2003, “Impact of Transport and Drug Properties on the Local Pharmacology of Drug-Eluting Stents,” Int. J. Cardiovasc. Interv., 5(1), pp. 7–12. Available at: http://web.mit.edu/hst-program/erelab/Publications/2003%20Papers/HwangImpactReview2003.pdf
Kang, S. J., Mintz, G. S., Park, D. W., Lee, S. W., Kim, Y. H., Whan Lee, C., Han, K. H., Kim, J. J., Park, S. W., and Park, S. J., 2011, “Mechanisms of In-Stent Restenosis After Drug-Eluting Stent Implantation: Intravascular Ultrasound Analysis,” Circul. Cardiovasc. Interv., 4(1), pp. 9–14. [CrossRef]
Keyes, J. T., Lockwood, D. R., Simon, B. R., and Vande Geest, J. P., 2013, “Deformationally Dependent Fluid Transport Properties of Porcine Coronary Arteries Based on Location in the Coronary Vasculature,” J. Mech. Bev. Biomed. Mat., 17, pp. 296–306. [CrossRef]
Levin, A. D., Vukmirovic, N., Hwang, C. W., and Edelman, E. R., 2004, “Specific Binding to Intracellular Proteins Determines Arterial Transport Properties for Rapamycin and Paclitaxel,” PNAS USA, 101(25), pp. 9463–9467. [CrossRef] [PubMed]
Lovich, M. A., Creel, C., Hong, K., Hwang, C. W., and Edelman, E. R., 2001, “Carrier Proteins Determine Local Pharmacokinetics and Arterial Distribution of Paclitaxel,” J. Pharm. Sci., 90(9), pp. 1324–1335. [CrossRef] [PubMed]
Wan, W. K., Lovich, M. A., Hwang, C. W., and Edelman, E. R., 1999, “Measurement of Drug Distribution in Vascular Tissue Using Quantitative Fluorescence Microscopy,” J. Pharm. Sci., 88(8), pp. 822–829. [CrossRef] [PubMed]
Zhu, X., Pack, D. W., and Braatz, R. D., 2012, “Modelling Intravascular Delivery From Drug-Eluting Stents With Biodurable Coating: Investigation of Anisotropic Vascular Drug Diffusivity and Arterial Drug Distribution,” Comput. Meth. Biomech. Biomed. Eng. (in press). [CrossRef]
Samady, H., Eshtehardi, P., McDaniel, M. C., Suo, J., Dhawan, S. S., Maynard, C., Timmins, L. H., Quyyumi, A. A., and Giddens, D. P., 2011, “Coronary Artery Wall Shear Stress Is Associated With Progression and Transformation of Atherosclerotic Plaque and Arterial Remodeling in Patients With Coronary Artery Disease,” Circulation, 124(7), pp. 779–788. [CrossRef] [PubMed]
He, X., and Ku, D. N., 1996, “Pulsatile Flow in the Human Left Coronary Artery Bifurcation: Average Conditions,” ASME, J. Biomech. Eng., 118(1), pp. 74–82. [CrossRef]
Krams, R., Wentzel, J. J., Oomen, J. A., Vinke, R., Schuurbiers, J. C., de Feyter, P. J., Serruys, P. W., and Slager, C. J., 1997, “Evaluation of Endothelial Shear Stress and 3D Geometry as Factors Determining the Development of Atherosclerosis and Remodeling in Human Coronary Arteries In Vivo. Combining 3D Reconstruction From Angiography and IVUS (ANGUS) With Computational Fluid Dynamics,” Arteriosc. Throm. Vasc. Biol., 17(10), pp. 2061–2065. [CrossRef]
Weydahl, E. S., and Moore, J. E., 2001, “Dynamic Curvature Strongly Affects Wall Shear Rates in a Coronary Artery Bifurcation Model,” J. Biomech., 34(9), pp. 1189–1196. [CrossRef] [PubMed]
Plata, A. M., Sherwin, S. J., and Krams, R., 2010, “Endothelial Nitric Oxide Production and Transport in Flow Chambers: The Importance of Convection,” Ann. Biomed. Eng., 38(9), pp. 2805–2816. [CrossRef] [PubMed]
Tarbell, J. M., 2003, “Mass Transport in Arteries and the Localization of Atherosclerosis,” Ann. Rev. Biomed. Eng., 5, pp. 79–118. [CrossRef]
O'Connell, B. M., McGloughlin, T. M., and Walsh, M. T., 2010, “Factors That Affect Mass Transport From Drug Eluting Stents Into the Artery Wall,” Biomed. Eng. Online, 9, p. 15. [CrossRef] [PubMed]
Keyes, J. T., Simon, B. R., and Vande Geest, J. P., 2012, “Location Dependent Coronary Artery Diffusive and Convective Mass Transport Properties of a Lipophilic Drug Surrogate Measured Using Nonlinear Microscopy,” Pharm. Res., 30(4), pp. 1147–1160. [CrossRef] [PubMed]
Feenstra, P. H., and Taylor, C. A., 2009, “Drug Transport in Artery Walls: A Sequential Porohyperelastic-Transport Approach,” Comput. Meth. Biomech. Biomed. Eng, 12(3), pp. 263–276. [CrossRef]
Wang, Z., Sun, A., Fan, Y., and Deng, X., 2012, “Comparative Study of Newtonian and Non-Newtonian Simulations of Drug Transport in a Model Drug-Eluting Stent,” Biorheology, 49(4), pp. 249–259. [PubMed]
Balakrishnan, B., Dooley, J. F., Kopia, G., and Edelman, E. R., 2007, “Intravascular Drug Release Kinetics Dictate Arterial Drug Deposition, Retention, and Distribution,” J. Control. Release, 123(2), pp. 100–108. [CrossRef] [PubMed]
Goriely, A. R., Baldwin, A. L., and Secomb, T. W., 2007, “Transient Diffusion of Albumin in Aortic Walls: Effects of Binding to Medial Elastin Layers,” Am. J. Physiol., 292(5), pp. H2195–H2201. [CrossRef]
Balakrishnan, B., Tzafriri, A. R., Seifert, P., Groothuis, A., Rogers, C., and Edelman, E. R., 2005, “Strut Position, Blood Flow, and Drug Deposition: Implications for Single and Overlapping Drug-Eluting Stents,” Circulation, 111(22), pp. 2958–2965. [CrossRef] [PubMed]
Kolachalama, V. B., Levine, E. G., and Edelman, E. R., 2009, “Luminal Flow Amplifies Stent-Based Drug Deposition in Arterial Bifurcations,” PLoS One, 4(12), p. e8105. [CrossRef] [PubMed]
Kolachalama, V. B., Tzafriri, A. R., Arifin, D. Y., and Edelman, E. R., 2009, “Luminal Flow Patterns Dictate Arterial Drug Deposition in Stent-Based Delivery,” J. Control. Release, 133(1), pp. 24–30. [CrossRef] [PubMed]
Rappitsch, G., and Perktold, K., 1996, “Pulsatile Albumin Transport in Large Arteries: A Numerical Simulation Study,” ASME, J. Biomech. Eng., 118(4), pp. 511–519. [CrossRef]
Vairo, G., Cioffi, M., Cottone, R., Dubini, G., and Migliavacca, F., 2010, “Drug Release From Coronary Eluting Stents: A Multidomain Approach,” J. Biomech., 43(8), pp. 1580–1589. [CrossRef] [PubMed]
Vande Geest, J. P., Simon, B. R., Rigby, P. H., and Newberg, T. P., 2011, “Coupled Porohyperelastic Mass Transport (PHEXPT) Finite Element Models for Soft Tissues Using ABAQUS,” ASME, J. Biomech. Eng., 133(4), p. 044502. [CrossRef]
Ayyalasomayajula, A., Vande Geest, J. P., and Simon, B. R., 2010, “Porohyperelastic Finite Element Modeling of abdominal Aortic Aneurysms,” ASME, J. Biomech. Eng., 132(10), p. 104502. [CrossRef]
Simulia, 2010, “Abaqus 6.98 Documentation,” Abaqus Theory Manual, D. Systemes, ed.France.
Holzapfel, G. A., and Weizsacker, H. W., 1998, “Biomechanical Behavior of the Arterial Wall and Its Numerical Characterization,” Comput. Biol. Med., 28(4), pp. 377–392. [CrossRef] [PubMed]
Medtronic, I., 2012, “Resolute Integrity Zotarolimus-Eluting Coronary Stent System Over the Wire Delivery System: Instructions for Use.”
Medtronic, I., 2012, “FDA Summary of Safety and Effectiveness Data (SSED) PMA Number: P110013,” F. a. D. Administration, ed.
Dirschinger, J., Kastrati, A., Neumann, F. J., Boekstegers, P., Elezi, S., Mehilli, J., Schuhlen, H., Pache, J., Alt, E., Blasini, R., Steinbeck, G., and Schomig, A., 1999, “Influence of Balloon Pressure During Stent Placement in Native Coronary Arteries on Early and Late Angiographic and Clinical Outcome: A Randomized Evaluation of High-Pressure Inflation,” Circulation, 100(9), pp. 918–923. [CrossRef] [PubMed]
Meredith, I. T., Worthley, S., Whitbourn, R., Walters, D., Popma, J., Cutlip, D., and Fitzgerald, P., 2007, “The Next-Generation Endeavor Resolute Stent: 4-Month Clinical and Angiographic Results From the Endeavor Resolute First-In-Man Trial,” EuroIntervention, 3(1), pp. 50–53. [PubMed]
Meredith, I. T., Ormiston, J., Whitbourn, R., Kay, I. P., Muller, D., Popma, J. J., Cutlip, D. E., and Fitzgerald, P. J., 2007, “Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, The First-In-Human Study,” Am. J. Cardiol., 100(8B), pp. 56M–61M. [CrossRef] [PubMed]
Seiler, C., Fleisch, M., Kaufmann, U., and Meier, B., 1997, “Measurements of Intracoronary Pressure and Blood Flow Velocity,” Praxis, 86(16), pp. 649–654. [PubMed]
Seiler, C., Kaufmann, U., and Meier, B., 1997, “Intracoronary Demonstration of Adenosine-Induced Coronary Collateral Steal,” Heart, 77(1), pp. 78–81. [PubMed]
Huo, Y., and Kassab, G. S., 2006, “Pulsatile Blood Flow in the Entire Coronary Arterial Tree: Theory and Experiment,” Am. J. Physiol., 291(3), pp. H1074–H1087. [CrossRef]
Ethier, C. R., 2002, “Computational Modeling of Mass Transfer and Links to Atherosclerosis,” Ann. Biomed. Eng., 30(4), pp. 461–471. [CrossRef] [PubMed]
Yang, C., and Burt, H. M., 2006, “Drug-Eluting Stents: factors Governing Local Pharmacokinetics,” Adv. Drug Del. Rev., 58(3), pp. 402–411. [CrossRef]
Rogers, C., Tseng, D. Y., Squire, J. C., and Edelman, E. R., 1999, “Balloon-Artery Interactions During Stent Placement: A Finite Element Analysis Approach to Pressure, Compliance, and Stent Design as Contributors to Vascular Injury,” Circul. Res., 84(4), pp. 378–383. [CrossRef]
Hwang, C. W., and Edelman, E. R., 2002, “Arterial Ultrastructure Influences Transport of Locally Delivered Drugs,” Circul. Res., 90(7), pp. 826–832. [CrossRef]
Fischer, G. M., and Llaurado, J. G., 1966, “Collagen and Elastin Content in Canine Arteries Selected From Functionally Different Vascular Beds,” Circul. Res., 19(2), pp. 394–399. [CrossRef]
Swindle, M. M., Horneffer, P. J., Gardner, T. J., Gott, V. L., Hall, T. S., Stuart, R. S., Baumgartner, W. A., Borkon, A. M., Galloway, E., and Reitz, B. A., 1986, “Anatomic and Anesthetic Considerations in Experimental Cardiopulmonary Surgery in Swine,” Lab. Animal Sci., 36(4), pp. 357–361.
Vilahur, G., Padro, T., and Badimon, L., 2011, “Atherosclerosis and Thrombosis: Insights From Large Animal Models,” J. Biomed. Biotech., 2011, p. 907575. [CrossRef]
Denardo, S. J., Carpinone, P. L., Vock, D. M., Batich, C. D., and Pepine, C. J., 2012, “Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion,” JAMA, 307(20), pp. 2148–2150. [CrossRef] [PubMed]
Wakabayashi, K., Mintz, G. S., Weissman, N. J., Stone, G. W., Ellis, S. G., Grube, E., Ormiston, J. A., Turco, M. A., Pakala, R., Xue, Z., Desale, S., Laynez-Carnicero, A., Romaguera, R., Sardi, G., Pichard, A. D., and Waksman, R., 2012, “Impact of Drug-Eluting Stents on Distal Vessels,” Circul. Cardiovasc. Interv., 5(2), pp. 211–219. [CrossRef]
Baldwin, A. L., Wilson, L. M., Gradus-Pizlo, I., Wilensky, R., and March, K., 1997, “Effect of Atherosclerosis on Transmural Convection an Arterial Ultrastructure. Implications for Local Intravascular Drug Delivery,” Arteriosc. Throm. Vasc. Biol., 17(12), pp. 3365–3375. [CrossRef]
Lovich, M. A., Philbrook, M., Sawyer, S., Weselcouch, E., and Edelman, E. R., 1998, “Arterial Heparin Deposition: Role of Diffusion, Convection, and Extravascular Space,” Am. J. Physiol., 275(6), pp. H2236–2242. [PubMed]
Boerckel, J. D., Uhrig, B. A., Willett, N. J., Huebsch, N., and Guldberg, R. E., 2011, “Mechanical Regulation of Vascular Growth and Tissue Regeneration In Vivo,” PNAS USA, 108(37), pp. E674–E680. [CrossRef] [PubMed]
Humphrey, J. D., 2009, “Vascular Mechanics, Mechanobiology, and Remodeling,” J. Mech. Med. Biol., 9(2), pp. 243–257. [CrossRef] [PubMed]
Cheng, J. K., and Wagenseil, J. E., 2012, “Extracellular Matrix and the Mechanics of Large Artery Development,” Biomech Model Mechanobiol., 11(8), pp. 1169–1186. [CrossRef] [PubMed]
Gerthoffer, W. T., 2007, “Mechanisms of Vascular Smooth Muscle Cell Migration,” Circul. Res., 100(5), pp. 607–621. [CrossRef]
Zhang, B. C., Zhou, Z. W., Li, X. K., and Xu, Y. W., 2011, “PI-3K/AKT Signal Pathway Modulates Vascular Smooth Muscle Cells Migration Under Cyclic Mechanical Strain,” VASA. Zeitschrift fur Gefasskrankheiten, 40(2), pp. 109–116. [CrossRef] [PubMed]
Serruys, P. W., Degertekin, M., Tanabe, K., Russell, M. E., Guagliumi, G., Webb, J., Hamburger, J., Rutsch, W., Kaiser, C., Whitbourn, R., Camenzind, E., Meredith, I., Reeves, F., Nienaber, C., Benit, E., Disco, C., Koglin, J., and Colombo, A., 2004, “Vascular Responses at Proximal and Distal Edges of Paclitaxel-Eluting Stents: Serial Intravascular Ultrasound Analysis From the TAXUS II Trial,” Circulation, 109(5), pp. 627–633. [CrossRef] [PubMed]
Poon, M., Marx, S. O., Gallo, R., Badimon, J. J., Taubman, M. B., and Marks, A. R., 1996, “Rapamycin Inhibits Vascular Smooth Muscle Cell Migration,” J. Clin. Invest., 98(10), pp. 2277–2283. [CrossRef] [PubMed]
Burke, S. E., Kuntz, R. E., and Schwartz, L. B., 2006, “Zotarolimus (ABT-578) Eluting Stents,” Adv. Drug Del. Rev., 58(3), pp. 437–446. [CrossRef]
Odahara, T. M. H., and Chiba, A., 2008, “Mechanical Properties of Biomedical Co-33Cr-5Mo-0.3N Alloy at Elevated Temperatures,” Mater. Trans., 49(9), pp. 1963–1969. [CrossRef]

Figures

Grahic Jump Location
Fig. 1

(a) Top: geometry with representative 1/20 symmetry. Bottom: representative mesh with closeup in inset. (b) Resolute Integrity® release profile used in the simulations (adapted from Ref. [33]).

Grahic Jump Location
Fig. 2

Geometry planes and lines for evaluation. (a) is the planar cut at the end of the stent. i is the line of nodes at the midradius around the θ direction at the end of the stent. ii is the line of nodes in mid-θ along the radius at the end of the stent. (b) is the planar cut in the middle of the stent. iii is the line of nodes at the midradius around the θ direction in the middle of the stent. iv is the line of nodes in mid-θ along the radius in the middle of the stent. (c) is the planar cut at mid-θ. v is the line of nodes at midradius along the length of the vessel section. iv is the line of nodes at the inner surface of the artery along the length of the vessel section.

Grahic Jump Location
Fig. 3

Mechanical metrics between section. Top is the maximum principal stress and bottom is the maximum principal strain. Values are averaged over all elements in either the stented or nonstented regions. Contour plot shows a representative maximum principal stress contour plot (in Pa) from a RCA proximal section.

Grahic Jump Location
Fig. 4

(a and b) vfr at line scan v along the length for the different vessel sections. The arrows represent the stented sections of the vessels. Lengths along the vessels are normalized. (c) is the Pecletlike number between arterial sections (Eq. (9)).

Grahic Jump Location
Fig. 5

Representative vfr results (a), and concentration results at times of 18 (b), 36 (c), 72 (d), 126 (e), and 180 days (f). All contour plots are from RCA middle sections.

Grahic Jump Location
Fig. 6

Representative concentration values for the i, and iii regions over time for a RCA middle section

Grahic Jump Location
Fig. 7

Average values 2over the ii and iv scans over times of 9, 30, and 180 days for (a), (b), and (c), respectively

Grahic Jump Location
Fig. 8

Representative concentration (kg/m3) contour plots for right middle sections for a noncell-binding model (a) and a cell-binding model (b)

Tables

Errata

Discussions

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In